Table 2.
Recurrence-free Survival | Metastasis-free Survival | |||||||
---|---|---|---|---|---|---|---|---|
N | HR1 | 95% CI1 | p-value | N | HR1 | 95% CI1 | p-value | |
Grade Group (GG) | 986 | 983 | ||||||
1 | — | — | — | — | ||||
2 | 1.36 | 1.09, 1.71 | 0.007 | 2.42 | 1.52, 3.85 | <0.001 | ||
≥3 | 2.39 | 1.89, 3.03 | <0.001 | 5.03 | 3.18, 7.95 | <0.001 | ||
preopPSA | 895 | 1.04 | 1.03, 1.04 | <0.001 | 892 | 1.02 | 1.01, 1.03 | <0.001 |
Seminal Vesicle Invasion (SVI) | 983 | 981 | ||||||
Absent | — | — | — | — | ||||
Present | 2.98 | 2.25, 3.96 | <0.001 | 2.32 | 1.44, 3.72 | <0.001 | ||
Surgical Margin | 960 | 959 | ||||||
Absent | — | — | — | — | ||||
Present | 1.92 | 1.58, 2.33 | <0.001 | 1.24 | 0.87, 1.76 | 0.2 | ||
Extraprostatic Extension (EPE) | 984 | 981 | ||||||
Absent | — | — | — | — | ||||
Present | 1.98 | 1.64, 2.40 | <0.001 | 1.56 | 1.11, 2.18 | 0.01 | ||
Lymph Node Invasion | 676 | 673 | ||||||
Absent | — | — | — | — | ||||
Present | 4.15 | 2.81, 6.14 | <0.001 | 3.69 | 2.11, 6.43 | <0.001 | ||
cPTEN - Binary | 998 | 995 | ||||||
Intact | — | — | — | — | ||||
Loss | 1.66 | 1.36, 2.03 | <0.001 | 1.54 | 1.07, 2.21 | 0.019 | ||
cPTEN - Stratified | 998 | 995 | ||||||
Intact | — | — | — | — | ||||
Loss - Partial | 1.38 | 1.02,1.86 | 0.035 | 1.52 | 0.91, 2.54 | 0.11 | ||
Loss- Complete | 1.89 | 1.49,2.39 | <0.001 | 1.55 | 1.00, 2.41 | 0.049 | ||
AI-qPTEN - Continuous | 998 | 2.62 | 1.79, 3.82 | <0.001 | 995 | 4.12 | 2.28, 7.44 | <0.001 |
AI-qPTEN - Categorical | 998 | 995 | ||||||
Ref | — | — | — | — | ||||
High-Risk (>0.04) | 1.71 | 1.39, 2.11 | <0.001 | 2.55 | 1.83, 3.56 | <0.001 | ||
CAPRA-S | 594 | 593 | ||||||
Low | — | — | — | — | ||||
Intermediate | 2.63 | 1.98, 3.50 | <0.001 | 3.78 | 2.35, 6.08 | <0.001 | ||
High | 4.76 | 3.53, 6.44 | <0.001 | 3.21 | 1.89, 5.44 | <0.001 |
HR = Hazard Ratio, CI = Confidence Interval